CAS NO.1197953-54-0 ‍Product Name BrigatinibSynonymsAP26113FormulaC29H39ClN7O2PMolecular Weight584.10Spec / Purity98%minSupply Capacity Details Brigatinib (AP26113) is an investigational small-molecule targeted cancer therapy. Brigatinib has exhibited activity as a potent dual inhibitor of anaplastic lymphoma kinase (ALK) and epidermal growth factor receptor (EGFR).